ATE77074T1 - Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung. - Google Patents

Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung.

Info

Publication number
ATE77074T1
ATE77074T1 AT88903292T AT88903292T ATE77074T1 AT E77074 T1 ATE77074 T1 AT E77074T1 AT 88903292 T AT88903292 T AT 88903292T AT 88903292 T AT88903292 T AT 88903292T AT E77074 T1 ATE77074 T1 AT E77074T1
Authority
AT
Austria
Prior art keywords
pct
cancer
function
radiotherapy
targetted
Prior art date
Application number
AT88903292T
Other languages
English (en)
Inventor
Jacques Quivy
Marc Zeicher
Manuel Worcel
Original Assignee
Ire Celltarg Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ire Celltarg Sa filed Critical Ire Celltarg Sa
Application granted granted Critical
Publication of ATE77074T1 publication Critical patent/ATE77074T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0493—Steroids, e.g. cholesterol, testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88903292T 1987-04-17 1988-04-15 Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung. ATE77074T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8705524A FR2613937B1 (fr) 1987-04-17 1987-04-17 Ligands specifiques de recepteurs d'hormones steroides utiles pour la therapie ciblee ou l'imagerie medicale notamment du cancer
PCT/FR1988/000188 WO1988007986A2 (fr) 1987-04-17 1988-04-15 Composes utiles notamment pour la radiotherapie ou l'imagerie du cancer
EP88903292A EP0310645B1 (de) 1987-04-17 1988-04-15 Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung

Publications (1)

Publication Number Publication Date
ATE77074T1 true ATE77074T1 (de) 1992-06-15

Family

ID=9350264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88903292T ATE77074T1 (de) 1987-04-17 1988-04-15 Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung.

Country Status (8)

Country Link
US (1) US5096694A (de)
EP (1) EP0310645B1 (de)
JP (1) JP2708204B2 (de)
AT (1) ATE77074T1 (de)
CA (1) CA1325803C (de)
DE (1) DE3871892T2 (de)
FR (1) FR2613937B1 (de)
WO (1) WO1988007986A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2637803B1 (fr) * 1988-10-19 1993-07-09 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese
WO1990012321A1 (en) * 1989-03-31 1990-10-18 The Cancer Institute Board Halogenated dna ligand radiosensitisers for cancer therapy
US5641764A (en) * 1989-03-31 1997-06-24 Peter Maccallum Institute Halogenated DNA ligand radiosensitizers for cancer therapy
AU639920B2 (en) * 1989-03-31 1993-08-12 Anti-Cancer Council Of Victoria Halogenated dna ligand radiosensitisers for cancer therapy
US5427766A (en) * 1993-11-15 1995-06-27 The Dow Chemical Company Radiolabeled steroids for use in radiochemical-guided surgery
EP0757559A4 (de) * 1994-04-29 1999-06-23 Molecular Medicine Center Zusammensetzung zur verabreichung von toxischen radioisotopen in den zellkern und ihre verwendung
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
SE513149C2 (sv) * 1997-12-05 2000-07-17 Katarina Edwards Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna
US6547812B1 (en) 2000-12-29 2003-04-15 Advanced Cardiovascular Systems, Inc. Radiation therapy using a radioactive implantable device and a radiosensitizer agent
US7220730B2 (en) * 2003-09-25 2007-05-22 Board Of Regents Of The University Of Nebraska Cancer specific radiolabeled conjugates regulated by the cell cycle for the treatment and diagnosis of cancer
CN1321127C (zh) * 2005-04-06 2007-06-13 江苏省原子医学研究所 碘(*i)-23-羟基白桦酸及其制备方法和应用
WO2008109080A2 (en) * 2007-03-01 2008-09-12 Siemens Medical Solutions Usa, Inc. Nucleoside based proliferation imaging markers
JP2014062054A (ja) * 2012-09-20 2014-04-10 Gyoseiin Genshino Iinkai Kakuno Kenkyusho よう素−123標記チミン類似物[123I]−IaraUのプローブ

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE518547C (de) * 1931-02-17 Buderus Eisenwerk Verfahren zur Herstellung von Schleudergussrohren
NL7405626A (nl) * 1974-04-26 1975-10-28 Akzo Nv Nieuwe 11-gesubstitueerde steroiden van de oestraanreeks.
US4465676A (en) * 1980-04-09 1984-08-14 New England Nuclear Corporation 16α Halogen substituted 3,17β-dihydroxy steroidal estrogens
US4541957A (en) * 1983-09-07 1985-09-17 The George Washington University Process for preparing iodovinyl-estradiol
DE3337179A1 (de) * 1983-10-10 1985-05-23 Schering AG, 1000 Berlin und 4709 Bergkamen Estran- und androstan-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende praeparate
JPS60126231A (ja) * 1983-12-09 1985-07-05 Seitai Kagaku Kenkyusho:Kk 放射性診断剤
DE3427795A1 (de) * 1984-07-25 1986-02-06 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 17(alpha)-halogenvinyl-estran-derivate, ihre herstellung und verwendung in der medizin
US4882141A (en) * 1984-10-22 1989-11-21 Bio-Medical Research Laboratories, Inc. Tissue imaging utilizing labelled steroids
US5104637A (en) * 1985-02-06 1992-04-14 University Of Cincinnati Radio labeled dihematophorphyrin ether and its use in detecting and treating neoplastic tissue
EP0263877A1 (de) * 1986-04-11 1988-04-20 The President And Fellows Of Harvard College Dihydrorhodamine und halogenierte derivate daraus
FR2637803B1 (fr) * 1988-10-19 1993-07-09 Ire Celltarg Sa Ligands specifiques de recepteurs d'hormones steroides estrogenes et progestagenes, application et produits intermediaires de synthese

Also Published As

Publication number Publication date
JP2708204B2 (ja) 1998-02-04
WO1988007986A2 (fr) 1988-10-20
EP0310645A1 (de) 1989-04-12
DE3871892D1 (de) 1992-07-16
WO1988007986A3 (fr) 1988-12-01
FR2613937A1 (fr) 1988-10-21
US5096694A (en) 1992-03-17
FR2613937B1 (fr) 1989-07-21
DE3871892T2 (de) 1993-02-04
CA1325803C (fr) 1994-01-04
EP0310645B1 (de) 1992-06-10
JPH01503708A (ja) 1989-12-14

Similar Documents

Publication Publication Date Title
DE3871892D1 (de) Verbindungen zur verwendung in der radiotherapie oder zur krebsvisualisierung.
SE7806390L (sv) Anleggning for diagnostisk rontgenbestralning enligt olika, anatomiskt baserade program
DK0567585T3 (da) Hepatisk vækstfaktorreceptor er met-protoonkogenet
ZIELINSKI et al. 16 α-[125I] Iodo-11 β Methoxy-17 β-Estradiol: A Radiochemical Probe for Estrogen-Sensitive Tissues
NL7600104A (nl) Dragermateriaal voor plaatsbepaling met radio-ak- tieve isotopen in medisch onderzoek en werkwijze voor de bereiding daarvan.
Bigott et al. Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors
Wenzel et al. Biochemistry of metalocenes. I. Distribution of 59Fe or 103Ru-labeled metalocene carboxylic acid in mice
DK327485D0 (da) 17alfa-halogenvinyloestranderivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemiddel
DeSombre et al. Bromine-80m radiotoxicity and the potential for estrogen receptor-directed therapy with Auger electrons
DK484584A (da) Oestran- og androstanderivater, fremgangsmaade til deres fremstilling og praeparater indeholdende disse forbindelser
US4508704A (en) Radioactive metals complexed with phosphonate derivatives of bicycloheptane bis(alkylamines)
DE68914087D1 (de) Spezifische Liganden für Östrogen- und Progestagen-Steroidhomonrezeptoren, deren Verwendung und Synthesezwischenprodukte.
ATE96444T1 (de) 3-methylen-4-androsten-17-one, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
September1975 mird1DOSEESTIMATEREPORTNO. 5
Forbes et al. Determination of specific activity of sodium in bone.
Rosenthal et al. PROGRESS REPORT: RELATIONSHIP OF PLUTONIUM REMOVAL TO TUMOR INCIDENCE
O'connor et al. The radiobiological response of the thyroid. Part II: Response of sheep thyroid cell in vitro to single doses of X rays
Norwood The determination of injury from the internally deposited radioisotope plutonium
Hosain et al. Radiopharmaceuticals for therapy in malignant diseases.
Ford et al. Tabulation of specific effective energies for dose calculations
Feagin Atomic Effects in Nuclear Reactions.
Ash et al. Biliary and faecal excretion of misonidazole in man
Prohazka et al. The fate of heterologous antigen (131I-HSA) in the organs of chickens exposed to total-body X-irradiation before a secondary antigenic stimulus
van Zyl Influence of the state of thyroid activtiy on hepatic metabolism of triiodothyronine
Halpern et al. Radiopharmaceutical testing